Results 151 to 160 of about 28,620 (235)

Routine CYP2C19 Genotyping, Antiplatelet Prescription Changes, and Clinical Outcomes After PCI in Chinese Patients With Coronary Heart Disease: A Single-Center Retrospective Study. [PDF]

Cardiol Res Pract
Niu D, Zhang M, Guan H.
europepmc   +1 more source

CYP2C19*3 Allele [PDF]

, 2020
openaire   +1 more source

Clinical and Genetic Factors Associated with Multivessel Coronary Artery Disease: A Cross-Sectional Study of CYP2C19 Polymorphisms and Metabolic Comorbidities. [PDF]

Int J Gen Med
Cai N, Li Y, Liu J, Hong H, Huang C, Li H, Li M, Peng J.   +7 more
europepmc   +1 more source

CYP2C19*6 Allele [PDF]

, 2020
openaire   +1 more source

Distribution of CYP2C19 polymorphism and predicted metabolizer phenotypes in the Indian population: A systematic review. [PDF]

Indian J Pharmacol
Singh S, Goyal C, Patel TK, Hada V, Bhusal CK, Bhalla HL, Saurabh MK.   +6 more
europepmc   +1 more source

Pharmacogenetic, Clinical, Prescribing, and Demographic Predictors of Sertraline Pharmacokinetics. [PDF]

Pharmaceutics
de la Cruz CG, Thomas L, Mata-Martín C, Villatoro-García JA, de Andrés F, González-Rodríguez I, González-Martínez I, Peñas-Lledó EM, LLerena A.   +8 more
europepmc   +1 more source

Convergent Modifiers of Exposure Variability in Approved Cannabinoid Medicines: Pharmacogenomics, Drug-Drug Interactions, and Parent-Metabolite Divergence. [PDF]

Pharmaceutics
Bagher AM.
europepmc   +1 more source

Population Pharmacokinetic Models of Voriconazole in Pediatric Patients: A Systematic Review. [PDF]

Pharmaceutics
Wang X, Li M, Yuan X, Chen J.
europepmc   +1 more source

CYP2C19*5 Allele [PDF]

, 2020
openaire   +1 more source

CYP2C19 genotype and cardiovascular events.

JAMA, 2012
Siasos, Gerasimos, Tousoulis, Dimitris, Stefanadis, Christodoulos   +2 more
openaire   +2 more sources